Skip Navigation

Program Directors


David Goldsmith, MD

Assistant Professor, Department of Psychiatry and Behavior Sciences

Dr. David R. Goldsmith is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine and is the Associate Program Director for the Psychiatry Residency Research Track. He is also on Faculty in the Emory Behavioral Immunology Program. Dr. Goldsmith is currently funded from a K23 Career Development Award from the National Institute of Mental Health to investigate the impact of inflammatory cytokines on brain reward circuitry, motivational deficits, and negative symptoms in patients with schizophrenia. He is a former Chief Resident of the Emory Psychiatry Research Track and has been recognized a number of times for his research and teaching including the Emory Department of Psychiatry Residency Research Award, the Laughlin Fellowship from the American College of Psychiatrists, the Deans Teaching Award from the Emory University School of Medicine, the npj: Schizophrenia Poster Award from the Schizophrenia International Research Society, and a Travel Award from the Society of Biological Psychiatry. Dr. Goldsmith is co-director of the PSTAR (Persistent Symptoms: Treatment, Assesment, and Recovery) Clinic at Grady Memorial Hospital, where he treats patients with persistent symptoms of psychosis.


Michael Treadway, PhD

Associate Professor, Department of Psychology

Dr. Treadway is a clinical psychologist and neuroscientist focused on understanding the molecular and circuit-level mechanisms of psychiatric symptoms related to mood, anxiety, and decision-making. He received his PhD in clinical psychology from Vanderbilt University in 2012, and completed his clinical internship and post-doc at McLean Hospital/Harvard Medical School. As Director of the Translational Research in Affective Disorders Laboratory (TReADLab) in the Department of Psychology at Emory University, Dr. Treadway’s research employs a variety of methods, including multimodal neuroimaging techniques (fMRI, MRS, and PET), behavioral paradigms, computational modeling, and clinical/personality assessment. A particular interest has been the assessment of reward motivation in psychiatric populations, for which Dr. Treadway has developed several widely used behavioral measures


Andrew Miller, MD

William P. Timmie Professor of Psychiatry and Behavioral Sciences
Vice Chair of Research, Department of Psychiatry and Behavioral Sciences

Dr. Andrew H. Miller is William P. Timmie Professor and Vice Chair for Research in the Department of Psychiatry and Behavioral Sciences at the Emory University School of Medicine in Atlanta, Georgia. He is an internationally recognized expert in interactions between the brain and immune system as they relate to depression. His work has demonstrated that during immune activation, inflammatory cytokines can access the brain and interact with the metabolism of dopamine and glutamate, while altering neurocircuits relevant to motivation and reward as well as anxiety and alarm. Additionally, Dr. Miller and his group conducted the first clinical trial examining the efficacy of an immunotherapy (cytokine antagonist) for the treatment of depression. He has produced over 250 scholarly publications, won numerous research, teaching and mentoring awards, is an ISI highly cited researcher and is a Board-Certified Psychiatrist